NUVL Net Income Growth
-49.60%TTM
Period ending:
NUVL TTM Net Income YoY %%
-29.35%-238.59%
2021-12-312026-03-31
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
NUVL net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 18 observations from Dec 31, 2021 to Mar 31, 2026.
| Period ending | Net Income Growth |
|---|---|
| -49.5978% | |
| -63.1322% | |
| -70.0671% | |
| -97.7953% | |
| -106.7611% | |
| -106.5901% | |
| -96.655% | |
| -73.3752% | |
| -62.5853% | |
| -54.2002% | |
| -56.1901% | |
| -52.3216% | |
| -56.7318% | |
| -76.6455% | |
| -104.9454% | |
| -134.9094% | |
| -113.8652% | |
| -218.343% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All NUVL financial metrics · NUVL stock overview · How to interpret financial metrics